Ruth Mokgokong

15PUBLICATIONS
28CO-AUTHORS
Business process managementPredictive and prognostic markersInnate immunityPacific Peoples theory of change models for healthHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 04, 2026
Real-world healthcare resource utilization and cost burden of COVID-19 in commercially insured adults at high-risk of severe disease in the US: a retrospective database analysis.

|Jul 06, 2026
Evaluation of nirmatrelvir/ritonavir treatment for COVID-19 on health-related outcomes: a global economic value systematic literature review.

|Mar 20, 2026
Health-related quality of life in immunocompromised adults with mild-moderate COVID-19 treated with nirmatrelvir-ritonavir: results from the randomized, double-blinded EPIC-IC trial.

Ruth Mokgokong, Paul Cislo, Elena Tudone

|Oct 14, 2025
Symptom Alleviation/Resolution and Returns to Usual Health/Activities in Immunocompromised Adults with COVID-19 Treated with Nirmatrelvir-Ritonavir: Results from the EPIC-IC Trial.

Ruth Mokgokong, Paul Cislo, Elena Tudone

|Sep 25, 2025
Comparative safety and effectiveness of direct oral anticoagulants and warfarin in patients with venous thromboembolism in Finland, Norway and Sweden.

Waleed Ghanima, Hanna Pohjantähti, Dimitra Lambrelli

|Aug 20, 2025
Development and content validation of the Long COVID/ post-acute sequelae of COVID-19 (PASC) patient-reported outcome (PRO) instrument.

Dale Chandler, Benjamin Abramoff, Candace Bramson

Pageof 3

Frequent Collaborators

3 joint publications

Nadia Quignot

2 joint publications

Tendai Mugwagwa

2 joint publications

Laurent Bertoletti

2 joint publications

Jose Chaves